- Home
- VCSA vs DXR Comparison
VCSA vs DXR Comparison
Compare VCSA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCSA
- DXR
- Stock Information
- Founded
- VCSA 2009
- DXR 1970
- Country
- VCSA United States
- DXR United States
- Employees
- VCSA N/A
- DXR N/A
- Industry
- VCSA Computer Software: Prepackaged Software
- DXR Medical/Dental Instruments
- Sector
- VCSA Technology
- DXR Health Care
- Exchange
- VCSA Nasdaq
- DXR Nasdaq
- Market Cap
- VCSA 38.6M
- DXR 37.6M
- IPO Year
- VCSA N/A
- DXR N/A
- Fundamental
- Price
- VCSA $5.01
- DXR $8.09
- Analyst Decision
- VCSA Hold
- DXR Strong Buy
- Analyst Count
- VCSA 4
- DXR 1
- Target Price
- VCSA $7.50
- DXR $24.75
- AVG Volume (30 Days)
- VCSA 357.7K
- DXR 7.0K
- Earning Date
- VCSA 02-26-2025
- DXR 01-01-0001
- Dividend Yield
- VCSA N/A
- DXR N/A
- EPS Growth
- VCSA N/A
- DXR N/A
- EPS
- VCSA N/A
- DXR 0.35
- Revenue
- VCSA $949,936,000.00
- DXR $154,205.00
- Revenue This Year
- VCSA N/A
- DXR N/A
- Revenue Next Year
- VCSA N/A
- DXR N/A
- P/E Ratio
- VCSA N/A
- DXR $23.58
- Revenue Growth
- VCSA N/A
- DXR N/A
- 52 Week Low
- VCSA $2.07
- DXR $7.19
- 52 Week High
- VCSA $11.70
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- VCSA 66.93
- DXR 46.69
- Support Level
- VCSA $4.95
- DXR $8.01
- Resistance Level
- VCSA $5.17
- DXR $8.50
- Average True Range (ATR)
- VCSA 0.13
- DXR 0.29
- MACD
- VCSA -0.01
- DXR 0.07
- Stochastic Oscillator
- VCSA 65.93
- DXR 61.44
About VCSA Vacasa Inc.
Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.